Compliance Rate

Compliance Rate 66.67%
Compliant submissions 2
Incompliant submissions 1
Total trials 3

My Organizations' Clinical Trials

Showing 150 of 458 entries
View as:

Task-Based Grounding Program

Phase: N/A Priority: Normal
NCT ID: NCT04648553 Org: User:
Start: 12/03/20 End: 10/01/21 Due: 10/01/22

ICG Fluorescence Imaging in Trauma Patients

Phase: N/A Priority: Normal
NCT ID: NCT04245111 Org: User:
Start: 05/16/19 End: 11/18/22 Due: 11/18/23

FDA "Breakthrough Drugs": A Trial Testing the Effect of Alternative Language on Public Perceptions

Phase: N/A Priority: Normal
NCT ID: NCT02428556 Org: User:
Start: 06/30/14 End: 06/30/14 Due: 06/30/15

Low Frequency TMS for Depression in Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT03105700 Org: User:
Start: 04/01/17 End: 11/15/21 Due: 11/15/22

Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00039468 Org: User:
Start: 03/31/02 End: 02/29/08 Due: 02/28/09

Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00005812 Org: User:
Start: 01/31/00 End: 05/31/04 Due: 05/31/05

Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG

Phase: N/A Priority: Normal
NCT ID: NCT02916979 Org: User:
Start: 09/06/16 End: 02/11/22 Due: 02/11/23

The Effect of Cinnamon on HbA1c Among Adolescents With Type I Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00371800 Org: User:
Start: 10/31/05 End: 05/31/06 Due: 05/31/07

Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT01849952 Org: User:
Start: 10/09/13 End: 05/01/25 Due: 05/01/26

Noninvasive Monitoring in Lower Body Negative and Positive Pressure Tests

Phase: N/A Priority: Normal
NCT ID: NCT03671902 Org: User:
Start: 02/01/18 End: 03/30/18 Due: 03/30/19

A Microdose Evaluation Study of ABY-029 in Recurrent Glioma

Phase: N/A Priority: Normal
NCT ID: NCT02901925 Org: User:
Start: 02/13/17 End: 06/29/21 Due: 06/29/22

Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)

Phase: N/A Priority: Normal
NCT ID: NCT00215202 Org: User:
Start: 08/31/04 End: 01/31/07 Due: 01/31/08

Multicenter Sous Vide Frostbite

Phase: N/A Priority: Normal
NCT ID: NCT05280301 Org: User:
Start: 12/01/22 End: 11/25/24 Due: 11/25/25

EFFICACY: Hopewell Hospitalist: A Video Game Intervention to Increase Advance Care Planning by Hospitalists

Phase: N/A Priority: Normal
NCT ID: NCT04557930 Org: User:
Start: 07/01/20 End: 08/31/21 Due: 08/31/22

Helping Women Stay Up-To-Date With Cancer Screening By Using a Prevention Care Manager or Usual Care

Phase: N/A Priority: Normal
NCT ID: NCT00477646 Org: User:
Start: 07/31/07 End: 02/28/11 Due: 02/28/12

NIR Hypoxia Imaging of Breast Tumor Response to Neoadjuvant Chemotherapy in Vivo

Phase: N/A Priority: Normal
NCT ID: NCT01934114 Org: User:
Start: 08/31/10 End: 09/30/15 Due: 09/30/16

Meditative Movement for COPD Symptoms in Non-Smoking Flight Attendants

Phase: N/A Priority: Normal
NCT ID: NCT02612389 Org: User:
Start: 03/31/15 End: 07/17/20 Due: 07/17/21

Electrical Activity of Diaphragm as a Means to Predict Extubation Success in Preterm Infants

Phase: N/A Priority: Normal
NCT ID: NCT02144363 Org: User:
Start: 08/31/14 End: 10/31/15 Due: 10/31/16

Healthy Homes Study

Phase: N/A Priority: Normal
NCT ID: NCT05833334 Org: User:
Start: 06/01/23 End: 07/15/25 Due: 07/15/26

Comparison of Different Methods of Pain Control After Cesarean Section for Patients on Buprenorphine or Methadone

Phase: N/A Priority: Normal
NCT ID: NCT02091297 Org: User:
Start: 04/30/14 End: 04/30/14 Due: 04/30/15

Apremilast Therapy for Acute Gouty Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00997581 Org: User:
Start: 04/30/10 End: 12/31/10 Due: 12/31/11

Long Term Follow-up of Deep Brain Stimulation for Treatment-Resistant Depression

Phase: N/A Priority: Normal
NCT ID: NCT03360942 Org: User:
Start: 04/18/16 End: 09/30/22 Due: 09/30/23

Decision Aids in Cerebral Aneurysm Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02503553 Org: User:
Start: - End: - Due: -

Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT05933395 Org: User:
Start: 10/10/23 End: 10/31/31 Due: 10/31/32

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00085488 Org: User:
Start: 02/29/04 End: 02/28/06 Due: 02/28/07